Well that poster sure left it open for further indications, so let's hope your instinct is right. That's a good observation linking proven pembroluzimab efficacy to the second expansion cancer, I think it bodes well medically and commercially.
I noted the deliberate choice of language on that poster as it says "Other indications" not "An additional". A bold bit of marketing or a real expectation of how this trial will evolve? Definitely very interesting.
Well that poster sure left it open for further indications, so...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(1.04%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $191.1K | 3.932M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 7659918 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2748842 | 26 |
View Market Depth
| Last trade - 14.53pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |